《公司業績》敏華控股(01999.HK)半年純利9.88億元升31.9% 中期息增至13仙
敏華控股(01999.HK)公布截至今年9月底止中期業績,營業額103.58億元,按年升50.8%。純利9.88億元,按年升31.9%;每股基本盈利24.96仙。派中期息13仙,對上財年同期派10仙。
沙發及配套產品業務收入按年增長52.1%至70.59億元。集團中國市場主營業務收入約64億元,按年增長約52.6%,期內中國專賣店店舖數目淨增長1,247間。
北美市場主營銷售收入約25.6億元,按年增長約60.5%,於歐洲及其他海外地區的主營銷售收入約6.57億元,按年增長89.4%。整體毛利率36.2%,按年擴大1.2個百分點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.